A nurse is caring for a 32-year-old client diagnosed with a complete hydatidiform mole who underwent suction curettage 2 days ago. Which nursing intervention is the priority for this client?

Understanding Gestational Trophoblastic Disease (GTD) and the Post-Molar Follow-Up

A complete hydatidiform mole is a form of gestational trophoblastic disease (GTD) characterized by abnormal fertilization resulting in diffuse swelling of chorionic villi and the absence of a viable fetus. While suction curettage effectively evacuates the molar tissue, the clinical priority shifts immediately to surveillance. The trophoblastic cells that proliferated to form the mole can persist, invade the myometrium, or metastasize, transforming into gestational trophoblastic neoplasia (GTN). The most sensitive and reliable marker for detecting this malignant transformation is serial serum quantitative beta-human chorionic gonadotropin (beta-hCG) monitoring ^[1].

Why Beta-hCG Monitoring is the Priority Intervention

Beta-hCG is structurally analogous to thyroid-stimulating hormone (TSH), and in the context of a complete mole, levels can become markedly elevated, sometimes exceeding 100,000 mIU/mL. This molecular mimicry can cause biochemical thyrotoxicosis, a known complication . After evacuation, the primary goal is to confirm the absence of residual trophoblastic tissue. A plateau or rise in beta-hCG levels indicates persistent GTD or progression to GTN, which requires chemotherapy. The standard surveillance protocol, reflected in the correct answer, is to monitor beta-hCG levels weekly until they are undetectable (negative) for 3 consecutive weeks, followed by monthly monitoring for an extended period ^[1]. This rigorous schedule is essential because the early detection of GTN directly impacts the time to chemotherapy commencement and overall prognosis ^[1].

Analysis of Incorrect Options

Option 2: Encourage the client to attempt pregnancy within 6 months to prevent complications.
This is contraindicated. A new pregnancy would cause a physiological rise in beta-hCG, making it impossible to distinguish between a normal pregnancy and a recurrence or malignant transformation of GTD. Reliable surveillance requires strict contraception, typically for 6 to 12 months after beta-hCG levels normalize, not an immediate attempt at pregnancy.

Option 3: Administer prophylactic antibiotics to prevent infection.
While infection is a general post-operative risk, prophylactic antibiotics are not a standard recommendation following uncomplicated suction curettage for a molar pregnancy unless specific clinical signs of infection are present. The risk of silent uterine perforation, a rare but critical complication, does warrant vigilant assessment for signs like abdominal pain, tachycardia, or hypotension, but this is managed through clinical monitoring, not routine prophylactic antibiotics .

Option 4: Recommend immediate return to normal physical activities.
This is unsafe. Post-operative recovery requires pelvic rest and avoidance of strenuous activity to reduce the risk of hemorrhage. Furthermore, the patient requires close surveillance for complications like uterine perforation, which can present with delayed symptoms such as abdominal pain and hemodynamic instability days to weeks after the procedure . Immediate return to full activity would increase the risk of injury and mask early signs of complications.

Clinical Integration and Safety

The priority nursing intervention is rooted in the pathophysiology of GTD. The trophoblastic cells responsible for the mole secrete beta-hCG, and their persistence or malignant transformation is exclusively tracked by this biomarker. Delaying or failing to adhere to the strict beta-hCG monitoring schedule is a critical safety gap that can allow GTN to progress to a stage requiring more aggressive chemotherapy. The specialized GTD unit model described in the literature emphasizes that the primary outcome of care is the completion rate of beta-hCG monitoring, underscoring its role as the cornerstone of safe post-molar management ^[1]. While uterine perforation is a rare but life-threatening complication that requires clinical suspicion and prompt intervention, its detection is a secondary outcome of the overall surveillance process, which is anchored by beta-hCG trend analysis .